ACTU

Conviction 20HealthcareScan · Tue, Oct 13, 2026

Actuate Therapeutics, Inc. (ACTU) closed at $0.4580 (-28.85%) on Oct 13, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 2, -94.3% from its 52-week high, -92.4% year to date. Sector: Healthcare · Pharmaceutical Preparations.

ACTU$0.4580-28.85%

ResistanceSupportVol 14

Vol MA14 436.48K

Jul 16Aug 3Aug 20Sep 8Sep 25Oct 13

Why ACTU moved

From the StockSetups movers recaps that covered ACTU, newest first. A recap states what was known that day.

Jul 13, 2026Close+24.4%
Actuate was cited in Benzinga's intraday roundup of healthcare stocks on the move (July 13), but no specific press release, SEC filing, trial result, or partnership announcement was surfaced by web research as the driver.
Top Stock Movers Today — July 13, 2026: Why SOBR, AGEN & ACTU Surged →

Actuate Therapeutics, Inc.Pharmaceutical Preparationswww.actuatetherapeutics.com ↗

Price0.4580

Change-28.85%

Gap+3.65%

Rel volume7.22×

Avg volume364.72K

Avg $ vol250.69K

SMA 200.7716

SMA 501.05

SMA 2002.52

Price vs 50-56.47%

Price vs 200-81.83%

MA stackbearish

50/200 cross—

Supertrenddown · 0.9721

RSI (14)31

MACD hist-0.01

MACD crossbear · 2d

Stoch %K / %D2 / 5

ADX (14)22

+DI / −DI13 / 29

RSI divergence—

MACD divergence—

ATR %31.09%

ADR %16.75%

52w high8.09

52w low0.4580

From 52w high-94.34%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width72.03%

%B-0.06

Donchian pos1.78%

Donchian high1.05

Donchian low0.4473

AVWAP (52w high)2.23

vs AVWAP high-79.49%

AVWAP (52w low)0.5242

vs AVWAP low-12.62%

OBV trendDown

Chaikin MF (20)-0.28

Today vs 20d7.22×

Avg vol (14d)436.48K

Avg vol (20d)364.72K

Avg $ vol (20d)250.69K

Market cap11M

RS Rating2 / 99

RS 3m (vs SPY)-76.45%

RS 6m (vs SPY)-90.01%

RS line new highNo

Trend template0/8

Technical rank2.3

1 week-43.57%

1 month-55.53%

3 months-73.37%

6 months-77.98%

1 year-94.12%

YTD-92.40%

P/E-0.49

P/B11.12

P/S—

P/FCF—

EPS-1.06

Div yield—

ROE—

ROA-427.51%

Debt/Eq—

Current1.25

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth18.54%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value6.57M

Revenue—

Net income-4.87M

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out23.93M

Employees12

ListedTue, Aug 13, 2024

Free float9.54M

Float %40.3%

Short interest1.17M

Days to cover1.9d

Short volume69.5%

Squeeze score69 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank2.3 / 100

Group rank5 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.85

Support0.7721

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACTU

All disclosures →

No recent disclosed trades by Congress in ACTU. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACTU

Insider	Side	Shares	Value	Traded	Filed
SCHMITT DANIEL M President, CEO and Director · Common Stock · 2026-08-14	Exercise	272.06K	—	2026-08-14	2026-08-14
SCHMITT DANIEL M President, CEO and Director · Common Stock · 2026-08-14	Tax	120.52K	$122K	2026-08-14	2026-08-14
SCHMITT DANIEL M President, CEO and Director · Restricted Stock Units · 2026-08-14	Exercise	272.06K	—	2026-08-14	2026-08-14
Fletcher Aaron G.L. Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Zabrowski Dan Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
RONNEBERG AMY L Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
THOMSON TODD S Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Huber Martin H. Jr. Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Keyes Jason A Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Sawhney Roger Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22

SEC filings

EDGAR filings in ACTU · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.